nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxorubicin—bone cancer—meningioma	0.288	0.301	CtDrD
Doxorubicin—muscle cancer—meningioma	0.254	0.266	CtDrD
Doxorubicin—peripheral nervous system neoplasm—meningioma	0.211	0.22	CtDrD
Doxorubicin—sarcoma—meningioma	0.203	0.212	CtDrD
Doxorubicin—NOS1—brainstem—meningioma	0.000943	0.031	CbGeAlD
Doxorubicin—NDUFS3—brainstem—meningioma	0.000926	0.0304	CbGeAlD
Doxorubicin—AKR1A1—medulla oblongata—meningioma	0.000868	0.0285	CbGeAlD
Doxorubicin—ABCB8—cerebellum—meningioma	0.000825	0.0271	CbGeAlD
Doxorubicin—CBR3—cerebellum—meningioma	0.000795	0.0261	CbGeAlD
Doxorubicin—AKR1A1—spinal cord—meningioma	0.000774	0.0254	CbGeAlD
Doxorubicin—NDUFS7—spinal cord—meningioma	0.000703	0.0231	CbGeAlD
Doxorubicin—ABCB8—brain—meningioma	0.00067	0.022	CbGeAlD
Doxorubicin—NOS1—medulla oblongata—meningioma	0.000658	0.0216	CbGeAlD
Doxorubicin—NDUFS2—medulla oblongata—meningioma	0.000653	0.0215	CbGeAlD
Doxorubicin—NDUFS3—medulla oblongata—meningioma	0.000645	0.0212	CbGeAlD
Doxorubicin—CBR3—brain—meningioma	0.000645	0.0212	CbGeAlD
Doxorubicin—AKR1A1—cerebellum—meningioma	0.000613	0.0202	CbGeAlD
Doxorubicin—DHCR7—medulla oblongata—meningioma	0.000613	0.0202	CbGeAlD
Doxorubicin—NOS1—spinal cord—meningioma	0.000586	0.0193	CbGeAlD
Doxorubicin—NDUFS2—spinal cord—meningioma	0.000583	0.0191	CbGeAlD
Doxorubicin—NDUFS3—spinal cord—meningioma	0.000576	0.0189	CbGeAlD
Doxorubicin—YWHAG—medulla oblongata—meningioma	0.000563	0.0185	CbGeAlD
Doxorubicin—NDUFS7—cerebellum—meningioma	0.000558	0.0183	CbGeAlD
Doxorubicin—DHCR7—spinal cord—meningioma	0.000547	0.018	CbGeAlD
Doxorubicin—RALBP1—medulla oblongata—meningioma	0.000508	0.0167	CbGeAlD
Doxorubicin—YWHAG—spinal cord—meningioma	0.000502	0.0165	CbGeAlD
Doxorubicin—AKR1A1—brain—meningioma	0.000498	0.0164	CbGeAlD
Doxorubicin—CBR1—medulla oblongata—meningioma	0.000474	0.0156	CbGeAlD
Doxorubicin—AKR1C3—medulla oblongata—meningioma	0.000469	0.0154	CbGeAlD
Doxorubicin—NOS1—cerebellum—meningioma	0.000465	0.0153	CbGeAlD
Doxorubicin—NDUFS2—cerebellum—meningioma	0.000462	0.0152	CbGeAlD
Doxorubicin—NDUFS3—cerebellum—meningioma	0.000456	0.015	CbGeAlD
Doxorubicin—RALBP1—spinal cord—meningioma	0.000453	0.0149	CbGeAlD
Doxorubicin—NDUFS7—brain—meningioma	0.000453	0.0149	CbGeAlD
Doxorubicin—DHCR7—cerebellum—meningioma	0.000434	0.0143	CbGeAlD
Doxorubicin—POR—medulla oblongata—meningioma	0.000428	0.0141	CbGeAlD
Doxorubicin—CBR1—spinal cord—meningioma	0.000423	0.0139	CbGeAlD
Doxorubicin—AURKA—brain—meningioma	0.000421	0.0138	CbGeAlD
Doxorubicin—AKR1C3—spinal cord—meningioma	0.000418	0.0137	CbGeAlD
Doxorubicin—YWHAG—cerebellum—meningioma	0.000398	0.0131	CbGeAlD
Doxorubicin—POR—spinal cord—meningioma	0.000381	0.0125	CbGeAlD
Doxorubicin—NQO1—medulla oblongata—meningioma	0.00038	0.0125	CbGeAlD
Doxorubicin—NOS1—brain—meningioma	0.000378	0.0124	CbGeAlD
Doxorubicin—NDUFS2—brain—meningioma	0.000375	0.0123	CbGeAlD
Doxorubicin—NDUFS3—brain—meningioma	0.000371	0.0122	CbGeAlD
Doxorubicin—RALBP1—cerebellum—meningioma	0.000359	0.0118	CbGeAlD
Doxorubicin—DHCR7—brain—meningioma	0.000352	0.0116	CbGeAlD
Doxorubicin—ABCC10—medulla oblongata—meningioma	0.000339	0.0112	CbGeAlD
Doxorubicin—NQO1—spinal cord—meningioma	0.000339	0.0111	CbGeAlD
Doxorubicin—CBR1—cerebellum—meningioma	0.000335	0.011	CbGeAlD
Doxorubicin—AKR1C3—cerebellum—meningioma	0.000331	0.0109	CbGeAlD
Doxorubicin—YWHAG—brain—meningioma	0.000323	0.0106	CbGeAlD
Doxorubicin—ABCC10—spinal cord—meningioma	0.000303	0.00995	CbGeAlD
Doxorubicin—POR—cerebellum—meningioma	0.000302	0.00994	CbGeAlD
Doxorubicin—RALBP1—brain—meningioma	0.000292	0.00959	CbGeAlD
Doxorubicin—NOS3—brain—meningioma	0.000287	0.00944	CbGeAlD
Doxorubicin—CBR1—brain—meningioma	0.000272	0.00895	CbGeAlD
Doxorubicin—AKR1C3—brain—meningioma	0.000269	0.00884	CbGeAlD
Doxorubicin—NQO1—cerebellum—meningioma	0.000269	0.00883	CbGeAlD
Doxorubicin—POR—brain—meningioma	0.000246	0.00808	CbGeAlD
Doxorubicin—ABCC10—cerebellum—meningioma	0.00024	0.00789	CbGeAlD
Doxorubicin—NQO1—brain—meningioma	0.000218	0.00717	CbGeAlD
Doxorubicin—ABCG2—medulla oblongata—meningioma	0.000199	0.00653	CbGeAlD
Doxorubicin—ABCC3—brain—meningioma	0.000196	0.00644	CbGeAlD
Doxorubicin—CYP2D6—brainstem—meningioma	0.000195	0.00642	CbGeAlD
Doxorubicin—ABCC10—brain—meningioma	0.000195	0.00641	CbGeAlD
Doxorubicin—CYP1B1—cerebellum—meningioma	0.000189	0.0062	CbGeAlD
Doxorubicin—ABCG2—spinal cord—meningioma	0.000177	0.00583	CbGeAlD
Doxorubicin—ABCC1—cerebellum—meningioma	0.00017	0.00558	CbGeAlD
Doxorubicin—CYP1B1—brain—meningioma	0.000153	0.00504	CbGeAlD
Doxorubicin—CBR1—NRF2 pathway—PDGFB—meningioma	0.000147	0.0111	CbGpPWpGaD
Doxorubicin—NOS3—SHP2 signaling—PDGFB—meningioma	0.000146	0.011	CbGpPWpGaD
Doxorubicin—YWHAG—Activation of BH3-only proteins—TP53—meningioma	0.000141	0.0106	CbGpPWpGaD
Doxorubicin—ABCG2—cerebellum—meningioma	0.000141	0.00462	CbGeAlD
Doxorubicin—NOS2—Circadian rythm related genes—CST3—meningioma	0.000138	0.0104	CbGpPWpGaD
Doxorubicin—ABCC1—brain—meningioma	0.000138	0.00453	CbGeAlD
Doxorubicin—NOS1—Amyotrophic lateral sclerosis (ALS)—TP53—meningioma	0.000136	0.0103	CbGpPWpGaD
Doxorubicin—AURKA—Aurora A signaling—AKT1—meningioma	0.000132	0.00995	CbGpPWpGaD
Doxorubicin—CYP1B1—Aryl Hydrocarbon Receptor Pathway—HES1—meningioma	0.000121	0.00914	CbGpPWpGaD
Doxorubicin—YWHAG—Activation of BH3-only proteins—AKT1—meningioma	0.000119	0.00896	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism of nitric oxide—AKT1—meningioma	0.000117	0.00887	CbGpPWpGaD
Doxorubicin—ABCG2—brain—meningioma	0.000114	0.00375	CbGeAlD
Doxorubicin—NOS2—Rac1/Pak1/p38/MMP-2 pathway—ERBB2—meningioma	0.000112	0.00848	CbGpPWpGaD
Doxorubicin—NOS2—Signaling mediated by p38-alpha and p38-beta—TP53—meningioma	0.00011	0.00829	CbGpPWpGaD
Doxorubicin—YWHAG—Insulin-mediated glucose transport—AKT1—meningioma	0.000105	0.00796	CbGpPWpGaD
Doxorubicin—CYP2B6—brain—meningioma	0.000105	0.00346	CbGeAlD
Doxorubicin—YWHAG—Intrinsic Pathway for Apoptosis—TP53—meningioma	0.000101	0.00759	CbGpPWpGaD
Doxorubicin—YWHAG—PDGFR-beta signaling pathway—PDGFB—meningioma	9.95e-05	0.00751	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CST3—meningioma	9.85e-05	0.00743	CbGpPWpGaD
Doxorubicin—ABCB1—medulla oblongata—meningioma	9.8e-05	0.00322	CbGeAlD
Doxorubicin—AURKA—Integrin-linked kinase signaling—AKT1—meningioma	9.79e-05	0.00739	CbGpPWpGaD
Doxorubicin—NOS3—Angiogenesis—AKT1—meningioma	9.75e-05	0.00736	CbGpPWpGaD
Doxorubicin—YWHAG—SIDS Susceptibility Pathways—HES1—meningioma	9.74e-05	0.00735	CbGpPWpGaD
Doxorubicin—CYP2D6—cerebellum—meningioma	9.63e-05	0.00317	CbGeAlD
Doxorubicin—NDUFS7—Metabolism—ALAD—meningioma	9.6e-05	0.00725	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—ALAD—meningioma	9.6e-05	0.00725	CbGpPWpGaD
Doxorubicin—TOP2A—Circadian rythm related genes—CST3—meningioma	9.45e-05	0.00713	CbGpPWpGaD
Doxorubicin—RALBP1—EGF/EGFR Signaling Pathway—ERBB2—meningioma	9.19e-05	0.00694	CbGpPWpGaD
Doxorubicin—YWHAG—LKB1 signaling events—TP53—meningioma	9.11e-05	0.00688	CbGpPWpGaD
Doxorubicin—YWHAG—Class I PI3K signaling events mediated by Akt—AKT1—meningioma	9.07e-05	0.00685	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—ALAD—meningioma	9.03e-05	0.00682	CbGpPWpGaD
Doxorubicin—YWHAG—Trk receptor signaling mediated by PI3K and PLC-gamma—AKT1—meningioma	8.87e-05	0.00669	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—SMO—meningioma	8.84e-05	0.00667	CbGpPWpGaD
Doxorubicin—ABCB1—spinal cord—meningioma	8.74e-05	0.00287	CbGeAlD
Doxorubicin—NOS1—Rac1/Pak1/p38/MMP-2 pathway—TP53—meningioma	8.67e-05	0.00654	CbGpPWpGaD
Doxorubicin—NOS3—VEGFR2 mediated vascular permeability—AKT1—meningioma	8.61e-05	0.0065	CbGpPWpGaD
Doxorubicin—NQO1—NRF2 pathway—PDGFB—meningioma	8.56e-05	0.00646	CbGpPWpGaD
Doxorubicin—YWHAG—Intrinsic Pathway for Apoptosis—AKT1—meningioma	8.49e-05	0.00641	CbGpPWpGaD
Doxorubicin—NOS3—VEGFR1 specific signals—AKT1—meningioma	8.38e-05	0.00632	CbGpPWpGaD
Doxorubicin—TOP2A—Gastric Cancer Network 2—TP53—meningioma	8.28e-05	0.00625	CbGpPWpGaD
Doxorubicin—NOS3—Leptin signaling pathway—ERBB2—meningioma	7.97e-05	0.00601	CbGpPWpGaD
Doxorubicin—RALBP1—EGF/EGFR Signaling Pathway—PTEN—meningioma	7.84e-05	0.00592	CbGpPWpGaD
Doxorubicin—CYP2D6—brain—meningioma	7.83e-05	0.00257	CbGeAlD
Doxorubicin—DHCR7—Metabolism—ALAD—meningioma	7.68e-05	0.00579	CbGpPWpGaD
Doxorubicin—NOS1—Alzheimers Disease—TP53—meningioma	7.6e-05	0.00573	CbGpPWpGaD
Doxorubicin—YWHAG—a6b1 and a6b4 Integrin signaling—AKT1—meningioma	7.42e-05	0.0056	CbGpPWpGaD
Doxorubicin—NOS1—Rac1/Pak1/p38/MMP-2 pathway—AKT1—meningioma	7.32e-05	0.00552	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—ALAD—meningioma	7.16e-05	0.0054	CbGpPWpGaD
Doxorubicin—AURKA—EGF/EGFR Signaling Pathway—ERBB2—meningioma	7.15e-05	0.0054	CbGpPWpGaD
Doxorubicin—NOS1—Disease—AP1B1—meningioma	7.13e-05	0.00538	CbGpPWpGaD
Doxorubicin—ABCC3—Fluoropyrimidine Activity—TP53—meningioma	6.96e-05	0.00525	CbGpPWpGaD
Doxorubicin—YWHAG—FoxO family signaling—AKT1—meningioma	6.93e-05	0.00523	CbGpPWpGaD
Doxorubicin—ABCB1—cerebellum—meningioma	6.93e-05	0.00228	CbGeAlD
Doxorubicin—NOS2—Rac1/Pak1/p38/MMP-2 pathway—TP53—meningioma	6.54e-05	0.00493	CbGpPWpGaD
Doxorubicin—AURKA—Integrated Breast Cancer Pathway—PTEN—meningioma	6.45e-05	0.00487	CbGpPWpGaD
Doxorubicin—NOS3—Plasma membrane estrogen receptor signaling—AKT1—meningioma	6.35e-05	0.00479	CbGpPWpGaD
Doxorubicin—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—AKT1—meningioma	6.34e-05	0.00479	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—TSHB—meningioma	6.19e-05	0.00467	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—TSHB—meningioma	6.19e-05	0.00467	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—PLAUR—meningioma	6.1e-05	0.0046	CbGpPWpGaD
Doxorubicin—AURKA—EGF/EGFR Signaling Pathway—PTEN—meningioma	6.1e-05	0.0046	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—TSHB—meningioma	5.82e-05	0.00439	CbGpPWpGaD
Doxorubicin—YWHAG—Translocation of GLUT4 to the plasma membrane—AKT1—meningioma	5.82e-05	0.00439	CbGpPWpGaD
Doxorubicin—YWHAG—PDGFR-beta signaling pathway—PTEN—meningioma	5.69e-05	0.00429	CbGpPWpGaD
Doxorubicin—ABCB1—brain—meningioma	5.63e-05	0.00185	CbGeAlD
Doxorubicin—NOS2—AGE/RAGE pathway—AKT1—meningioma	5.59e-05	0.00422	CbGpPWpGaD
Doxorubicin—NOS2—HIF-1-alpha transcription factor network—AKT1—meningioma	5.59e-05	0.00422	CbGpPWpGaD
Doxorubicin—NOS2—Rac1/Pak1/p38/MMP-2 pathway—AKT1—meningioma	5.52e-05	0.00417	CbGpPWpGaD
Doxorubicin—NOS1—Spinal Cord Injury—TP53—meningioma	5.51e-05	0.00416	CbGpPWpGaD
Doxorubicin—YWHAG—mTOR signaling pathway—AKT1—meningioma	5.46e-05	0.00412	CbGpPWpGaD
Doxorubicin—ABCC3—NRF2 pathway—PDGFB—meningioma	5.43e-05	0.0041	CbGpPWpGaD
Doxorubicin—NOS3—Angiopoietin receptor Tie2-mediated signaling—AKT1—meningioma	5.42e-05	0.00409	CbGpPWpGaD
Doxorubicin—NOS2—Disease—AP1B1—meningioma	5.38e-05	0.00406	CbGpPWpGaD
Doxorubicin—NOS3—Thromboxane A2 receptor signaling—AKT1—meningioma	4.95e-05	0.00373	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—TSHB—meningioma	4.95e-05	0.00373	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—AP1B1—meningioma	4.94e-05	0.00373	CbGpPWpGaD
Doxorubicin—ABCG2—Fluoropyrimidine Activity—TP53—meningioma	4.8e-05	0.00362	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—TSHB—meningioma	4.61e-05	0.00348	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—PLAUR—meningioma	4.6e-05	0.00347	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—TP53—meningioma	4.57e-05	0.00345	CbGpPWpGaD
Doxorubicin—RALBP1—EGF/EGFR Signaling Pathway—AKT1—meningioma	4.52e-05	0.00341	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—PDGFB—meningioma	4.41e-05	0.00333	CbGpPWpGaD
Doxorubicin—AURKA—Integrated Breast Cancer Pathway—TP53—meningioma	4.4e-05	0.00332	CbGpPWpGaD
Doxorubicin—NOS3—AGE/RAGE pathway—AKT1—meningioma	4.34e-05	0.00327	CbGpPWpGaD
Doxorubicin—NOS3—EGF/EGFR Signaling Pathway—ERBB2—meningioma	4.3e-05	0.00325	CbGpPWpGaD
Doxorubicin—ABCC2—NRF2 pathway—PDGFB—meningioma	4.3e-05	0.00325	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—PLAU—meningioma	4.28e-05	0.00323	CbGpPWpGaD
Doxorubicin—NOS1—Disease—CST3—meningioma	4.24e-05	0.0032	CbGpPWpGaD
Doxorubicin—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—AKT1—meningioma	4.24e-05	0.0032	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—ALAD—meningioma	4.18e-05	0.00316	CbGpPWpGaD
Doxorubicin—NOS3—Disease—AP1B1—meningioma	4.18e-05	0.00315	CbGpPWpGaD
Doxorubicin—NOS2—Spinal Cord Injury—TP53—meningioma	4.16e-05	0.00314	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—ALAD—meningioma	4.03e-05	0.00304	CbGpPWpGaD
Doxorubicin—NOS2—Circadian rythm related genes—PTEN—meningioma	3.98e-05	0.003	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—TSHB—meningioma	3.92e-05	0.00296	CbGpPWpGaD
Doxorubicin—NOS3—Leptin signaling pathway—AKT1—meningioma	3.92e-05	0.00296	CbGpPWpGaD
Doxorubicin—YWHAG—ErbB1 downstream signaling—AKT1—meningioma	3.77e-05	0.00284	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—ALAD—meningioma	3.75e-05	0.00283	CbGpPWpGaD
Doxorubicin—AURKA—Integrated Breast Cancer Pathway—AKT1—meningioma	3.72e-05	0.00281	CbGpPWpGaD
Doxorubicin—NOS3—EGF/EGFR Signaling Pathway—PTEN—meningioma	3.67e-05	0.00277	CbGpPWpGaD
Doxorubicin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—meningioma	3.63e-05	0.00274	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—PLAUR—meningioma	3.57e-05	0.0027	CbGpPWpGaD
Doxorubicin—AURKA—EGF/EGFR Signaling Pathway—AKT1—meningioma	3.51e-05	0.00265	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—ALAD—meningioma	3.41e-05	0.00257	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—SMO—meningioma	3.33e-05	0.00252	CbGpPWpGaD
Doxorubicin—NOS3—Corticotropin-releasing hormone—AKT1—meningioma	3.33e-05	0.00251	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—PDGFB—meningioma	3.33e-05	0.00251	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—meningioma	3.32e-05	0.00251	CbGpPWpGaD
Doxorubicin—YWHAG—Apoptosis—TP53—meningioma	3.27e-05	0.00247	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—meningioma	3.24e-05	0.00245	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—PLAU—meningioma	3.23e-05	0.00243	CbGpPWpGaD
Doxorubicin—NOS2—Disease—CST3—meningioma	3.2e-05	0.00241	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—PGR—meningioma	3.2e-05	0.00241	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism of lipids and lipoproteins—PTEN—meningioma	3.03e-05	0.00228	CbGpPWpGaD
Doxorubicin—NOS3—VEGFA-VEGFR2 Pathway—AKT1—meningioma	2.95e-05	0.00222	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—CST3—meningioma	2.94e-05	0.00222	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—meningioma	2.91e-05	0.0022	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—meningioma	2.83e-05	0.00214	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism of lipids and lipoproteins—PTEN—meningioma	2.82e-05	0.00213	CbGpPWpGaD
Doxorubicin—NOS3—Signaling by VEGF—AKT1—meningioma	2.78e-05	0.0021	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—ALAD—meningioma	2.76e-05	0.00209	CbGpPWpGaD
Doxorubicin—YWHAG—Apoptosis—AKT1—meningioma	2.76e-05	0.00208	CbGpPWpGaD
Doxorubicin—TOP2A—Circadian rythm related genes—PTEN—meningioma	2.72e-05	0.00205	CbGpPWpGaD
Doxorubicin—NOS2—Circadian rythm related genes—TP53—meningioma	2.71e-05	0.00205	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—TSHB—meningioma	2.69e-05	0.00203	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—ALAD—meningioma	2.65e-05	0.002	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—TSHB—meningioma	2.6e-05	0.00196	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—PDGFB—meningioma	2.58e-05	0.00195	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—AP1B1—meningioma	2.54e-05	0.00192	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—PLAU—meningioma	2.51e-05	0.00189	CbGpPWpGaD
Doxorubicin—NOS1—Disease—HES1—meningioma	2.5e-05	0.00188	CbGpPWpGaD
Doxorubicin—NOS3—Disease—CST3—meningioma	2.48e-05	0.00187	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—TSHB—meningioma	2.42e-05	0.00182	CbGpPWpGaD
Doxorubicin—YWHAG—Membrane Trafficking—AKT1—meningioma	2.34e-05	0.00177	CbGpPWpGaD
Doxorubicin—ABCG2—HIF-1-alpha transcription factor network—AKT1—meningioma	2.33e-05	0.00176	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—TSHB—meningioma	2.2e-05	0.00166	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—HES1—meningioma	2.19e-05	0.00165	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TSHB—meningioma	2.17e-05	0.00164	CbGpPWpGaD
Doxorubicin—NOS1—Disease—PDGFB—meningioma	2.13e-05	0.00161	CbGpPWpGaD
Doxorubicin—NOS3—EGF/EGFR Signaling Pathway—AKT1—meningioma	2.12e-05	0.0016	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—ALAD—meningioma	2.08e-05	0.00157	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—ALAD—meningioma	2.01e-05	0.00152	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—meningioma	1.93e-05	0.00146	CbGpPWpGaD
Doxorubicin—NOS2—Disease—HES1—meningioma	1.88e-05	0.00142	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—PDGFB—meningioma	1.87e-05	0.00141	CbGpPWpGaD
Doxorubicin—TOP2A—Circadian rythm related genes—TP53—meningioma	1.86e-05	0.0014	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—SMO—meningioma	1.85e-05	0.00139	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TSHB—meningioma	1.84e-05	0.00139	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—ALAD—meningioma	1.83e-05	0.00138	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—TSHB—meningioma	1.78e-05	0.00134	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—PGR—meningioma	1.77e-05	0.00134	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—HES1—meningioma	1.73e-05	0.00131	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—TP53—meningioma	1.72e-05	0.0013	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—TSHB—meningioma	1.71e-05	0.00129	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—PTEN—meningioma	1.69e-05	0.00127	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—PTEN—meningioma	1.69e-05	0.00127	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	1.63e-05	0.00123	CbGpPWpGaD
Doxorubicin—NOS2—Disease—PDGFB—meningioma	1.61e-05	0.00121	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism of lipids and lipoproteins—PTEN—meningioma	1.59e-05	0.0012	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—PTEN—meningioma	1.59e-05	0.0012	CbGpPWpGaD
Doxorubicin—AURKA—Cell Cycle—TP53—meningioma	1.58e-05	0.00119	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—SMO—meningioma	1.56e-05	0.00118	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CST3—meningioma	1.51e-05	0.00114	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—PGR—meningioma	1.5e-05	0.00113	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—PDGFB—meningioma	1.48e-05	0.00112	CbGpPWpGaD
Doxorubicin—NOS3—Disease—HES1—meningioma	1.46e-05	0.0011	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—AKT1—meningioma	1.45e-05	0.0011	CbGpPWpGaD
Doxorubicin—NOS1—Disease—ERBB2—meningioma	1.43e-05	0.00108	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—PTEN—meningioma	1.35e-05	0.00102	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ALAD—meningioma	1.34e-05	0.00101	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—TSHB—meningioma	1.34e-05	0.00101	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—TP53—meningioma	1.3e-05	0.000979	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—TSHB—meningioma	1.29e-05	0.000977	CbGpPWpGaD
Doxorubicin—ABCB1—HIF-1-alpha transcription factor network—AKT1—meningioma	1.26e-05	0.000949	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—PTEN—meningioma	1.26e-05	0.000949	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—ERBB2—meningioma	1.25e-05	0.000946	CbGpPWpGaD
Doxorubicin—NOS3—Disease—PDGFB—meningioma	1.25e-05	0.000943	CbGpPWpGaD
Doxorubicin—NOS1—Disease—PTEN—meningioma	1.22e-05	0.000921	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—HES1—meningioma	1.21e-05	0.000914	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—TP53—meningioma	1.2e-05	0.000903	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—TSHB—meningioma	1.18e-05	0.000889	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—AKT1—meningioma	1.1e-05	0.000827	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—meningioma	1.09e-05	0.000825	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—PTEN—meningioma	1.09e-05	0.000822	CbGpPWpGaD
Doxorubicin—NOS2—Disease—ERBB2—meningioma	1.08e-05	0.000814	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—PTEN—meningioma	1.07e-05	0.000806	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—PTEN—meningioma	1.04e-05	0.000789	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—PDGFB—meningioma	1.04e-05	0.000782	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—HES1—meningioma	1.02e-05	0.000772	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—TP53—meningioma	1.01e-05	0.00076	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—ERBB2—meningioma	9.92e-06	0.000748	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ALAD—meningioma	9.88e-06	0.000746	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—AKT1—meningioma	9.72e-06	0.000733	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—AKT1—meningioma	9.72e-06	0.000733	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—meningioma	9.33e-06	0.000704	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ALAD—meningioma	9.31e-06	0.000703	CbGpPWpGaD
Doxorubicin—NOS2—Disease—PTEN—meningioma	9.2e-06	0.000694	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—AKT1—meningioma	9.14e-06	0.00069	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—HES1—meningioma	8.91e-06	0.000672	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—PDGFB—meningioma	8.75e-06	0.000661	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—TSHB—meningioma	8.63e-06	0.000651	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—AKT1—meningioma	8.5e-06	0.000642	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—PTEN—meningioma	8.46e-06	0.000638	CbGpPWpGaD
Doxorubicin—NOS3—Disease—ERBB2—meningioma	8.38e-06	0.000632	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—TP53—meningioma	8.37e-06	0.000632	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—PTEN—meningioma	8.19e-06	0.000618	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—meningioma	7.92e-06	0.000598	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—AKT1—meningioma	7.77e-06	0.000586	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PDGFB—meningioma	7.62e-06	0.000575	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—PTEN—meningioma	7.34e-06	0.000554	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—TP53—meningioma	7.29e-06	0.00055	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—AKT1—meningioma	7.25e-06	0.000547	CbGpPWpGaD
Doxorubicin—NOS3—Disease—PTEN—meningioma	7.14e-06	0.000539	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—PTEN—meningioma	7.08e-06	0.000534	CbGpPWpGaD
Doxorubicin—NOS1—Disease—AKT1—meningioma	7.03e-06	0.000531	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—ERBB2—meningioma	6.94e-06	0.000524	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—PTEN—meningioma	6.58e-06	0.000497	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—TSHB—meningioma	6.37e-06	0.00048	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—meningioma	6.37e-06	0.00048	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—AKT1—meningioma	6.16e-06	0.000465	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ALAD—meningioma	6.09e-06	0.000459	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—TSHB—meningioma	6e-06	0.000453	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—PTEN—meningioma	5.98e-06	0.000452	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—PTEN—meningioma	5.92e-06	0.000447	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—ERBB2—meningioma	5.87e-06	0.000443	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	5.38e-06	0.000406	CbGpPWpGaD
Doxorubicin—NOS2—Disease—AKT1—meningioma	5.3e-06	0.0004	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—ERBB2—meningioma	5.11e-06	0.000385	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—PTEN—meningioma	5e-06	0.000378	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—AKT1—meningioma	4.87e-06	0.000368	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PTEN—meningioma	4.85e-06	0.000366	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PTEN—meningioma	4.65e-06	0.000351	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PTEN—meningioma	4.35e-06	0.000329	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—AKT1—meningioma	4.23e-06	0.000319	CbGpPWpGaD
Doxorubicin—NOS3—Disease—AKT1—meningioma	4.12e-06	0.000311	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—AKT1—meningioma	4.08e-06	0.000308	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TP53—meningioma	4.04e-06	0.000305	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—TSHB—meningioma	3.92e-06	0.000296	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—AKT1—meningioma	3.79e-06	0.000286	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PTEN—meningioma	3.65e-06	0.000275	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PTEN—meningioma	3.53e-06	0.000266	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—AKT1—meningioma	3.45e-06	0.00026	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TP53—meningioma	3.41e-06	0.000258	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—AKT1—meningioma	3.41e-06	0.000258	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PTEN—meningioma	3.21e-06	0.000242	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—AKT1—meningioma	2.88e-06	0.000218	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—AKT1—meningioma	2.8e-06	0.000211	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—AKT1—meningioma	2.68e-06	0.000202	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—AKT1—meningioma	2.51e-06	0.000189	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PTEN—meningioma	2.35e-06	0.000177	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—AKT1—meningioma	2.1e-06	0.000159	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—AKT1—meningioma	2.03e-06	0.000153	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—AKT1—meningioma	1.85e-06	0.00014	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PTEN—meningioma	1.73e-06	0.000131	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PTEN—meningioma	1.63e-06	0.000123	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—AKT1—meningioma	1.36e-06	0.000102	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PTEN—meningioma	1.07e-06	8.07e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—AKT1—meningioma	1e-06	7.54e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—AKT1—meningioma	9.42e-07	7.11e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—AKT1—meningioma	6.16e-07	4.65e-05	CbGpPWpGaD
